# Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers

> **NCT01849965** · PHASE3 · TERMINATED · sponsor: **Integra LifeSciences Corporation** · enrollment: 396 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DRUG:** DSC127
- **DRUG:** placebo vehicle gel
- **DRUG:** Standard of Care gel, Aquasite

## Key facts

- **NCT ID:** NCT01849965
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2017-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01849965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01849965, "Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01849965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*